Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer

Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer

Saved in:

Bibliographic Details
Main Authors:	Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin
Format:	Article
Language:	English
Published:	Springer 2024-12-01
Series:	Journal of Cancer Research and Clinical Oncology
Online Access:	https://doi.org/10.1007/s00432-024-06048-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
by: Noor A. M. Bakker, et al.
Published: (2025-01-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
by: Peng Luo, et al.
Published: (2023-01-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01)

Natural products as part of triple negative breast cancer
by: Yozlem Kobakova, et al.
Published: (2025-01-01)

Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance
by: Zhikai Mai, et al.
Published: (2025-01-01)

Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
by: Parvin F. Peddi, et al.
Published: (2012-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
by: Yanfei Ma, et al.
Published: (2022-01-01)

Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
by: Andrew A. Davis, et al.
Published: (2012-01-01)

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01)

Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
by: Sima Kianpour Rad, et al.
Published: (2025-01-01)

Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
by: Karima Oualla, et al.
Published: (2020-01-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

Triple Negative Breast Cancer in Pregnancy and Postpartum: Two Case Reports in Hispanic Women
by: Ruchi Upadhyay, et al.
Published: (2015-01-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
by: Qi Xu, et al.
Published: (2024-10-01)

Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
by: Ming Liu, et al.
Published: (2025-01-01)

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
by: Nicole J. Toney, et al.
Published: (2025-01-01)

Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms
by: Zhengjie Shen, et al.
Published: (2022-01-01)

Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
by: Binyu Zhu, et al.
Published: (2025-01-01)

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01)

Impact of Paracoccus sp. EGY7 carotenoids on triple-negative breast cancer cells: invitro study
by: Karim Abdelazim, et al.
Published: (2025-02-01)

Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
by: Ahmad Aizat Abdul Aziz, et al.
Published: (2020-01-01)

Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance
by: Zhikai Mai, et al.
Published: (2025-01-01)

Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience
by: Artur Bocian, et al.
Published: (2024-12-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Assessment of Suspected Breast Lesions in Early-Stage Triple-Negative Breast Cancer during Follow-Up after Breast-Conserving Surgery Using Multiparametric MRI
by: Lamiss Mohamed Abd El Aziz Sad, et al.
Published: (2022-01-01)

Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
by: Caitlin M. Tressler, et al.
Published: (2025-03-01)

Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
by: Jason H. Winnike, et al.
Published: (2018-01-01)

DNA Ligase IV Prevents Replication Fork Stalling and Promotes Cellular Proliferation in Triple Negative Breast Cancer
by: Rashmi R. Joshi, et al.
Published: (2019-01-01)

Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism
by: Xiao-Qing Song, et al.
Published: (2025-02-01)

SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
by: Shihan Qian, et al.
Published: (2025-01-01)

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
by: Yang Zhou, et al.
Published: (2022-01-01)